A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery.
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Effect of Albumin-bound Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Patients Receiving Neoadjuvant Chemotherapy for Advanced Ovarian, Fallopian Tube or Peritoneal Cancer: A Phase 2 Single Center Clinical Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Safety of Genexol PM and Carboplatin as First-line Therapy in Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
- Status
- COMPLETED
- Phase
- N/A
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
- Status
- RECRUITING
- Phase
- NA
Development of a Patient Reported Outcome Measure for Advanced Ovarian Cancer Patients Receiving Surgical and Chemotherapy Treatment
- Status
- UNKNOWN
- Phase
- N/A
A Study to Investigate LYL797 in Adults With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients
- Status
- UNKNOWN
- Phase
- PHASE1
Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort Study
- Status
- UNKNOWN
- Phase
- N/A
Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With Breast Cancer Gene (BRCA) Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
An Exploratory Study of HRD Score in Chinese Ovarian Cancer Patients Benefiting From PARP Inhibitor Targeted Therapy
- Status
- UNKNOWN
- Phase
- N/A
MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients.
- Status
- RECRUITING
- Phase
- PHASE3
(VELA) Study of BLU-222 in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1